查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1333569

幹細胞檢測的全球市場

Stem Cell Assays
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球幹細胞檢測市場將達到 69 億美元

在 COVID-19 後不斷變化的商業格局中，全球幹細胞檢測市場預計 2022 年為 19 億美元，預計到 2030 年將達到 69 億美元，2022 年至 2030 年年複合成長率17.8%。成長。設備是本報告分析的細分市場之一，預計複合年成長率為 18.3%，到分析期結束時將達到 54 億美元。鑑於大流行後的持續復甦，未來八年套件細分市場的年複合成長率修正為 17.6%。

美國市場估計為5.508億美元，中國預計複合年成長率為16.5%

到 2022 年，美國幹細胞檢測市場預計將達到 5.508 億美元。中國作為全球第二大經濟體，預計在2022年至2030年的分析期內將以16.5%的複合年成長率成長，預計2030年市場規模將達到11億美元。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 16.2% 和 15.2%。在歐洲，德國的年複合成長率預計約為 12.8%。

受訪企業示例

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP15020

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Stem Cell Assays Market to Reach $6.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Stem Cell Assays estimated at US$1.9 Billion in the year 2022, is projected to reach a revised size of US$6.9 Billion by 2030, growing at aCAGR of 17.8% over the period 2022-2030. Instruments, one of the segments analyzed in the report, is projected to record 18.3% CAGR and reach US$5.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits segment is readjusted to a revised 17.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $550.8 Million, While China is Forecast to Grow at 16.5% CAGR

The Stem Cell Assays market in the U.S. is estimated at US$550.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 16.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.2% and 15.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.

Select Competitors (Total 44 Featured) -

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Stem Cell Assay - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cell Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Cell Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Differentiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Differentiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Isolation & Purification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Isolation & Purification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Proliferation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Proliferation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for hESCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for hESCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Stem Cell Assays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World 8-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 31: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Viability / Cytotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World 8-Year Perspective for Viability / Cytotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: USA 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: USA 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: USA 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Canada 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Canada 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Canada 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • JAPAN
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Japan 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Japan 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • CHINA
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 58: China Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: China 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: China 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: China 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • EUROPE
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Europe 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Europe 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 73: Europe 8-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • FRANCE
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: France 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: France 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: France 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • GERMANY
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Germany 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Germany 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Germany 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Italy 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Italy 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • UNITED KINGDOM
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 100: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 101: UK 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 103: UK 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 107: UK 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of World 8-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2023 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Rest of World 8-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2023 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World 8-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2023 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 131: Rest of World 8-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2023 & 2030

IV. COMPETITION